Interrupting breast cancer treatment for young women who desire pregnancy

Dr Partridge (POSITIVE co-chair for US through ALLIANCE, Rochester, Minnesota) and Dr Pagani (POSITIVE co-chair for International Breast Cancer Study Group, Bern, Switzerland) talk to ecancertv at SABCS 2015 about the POSITIVE study.

The study evaluates the pregnancy outcomes and safety of interrupting endocrine therapy for young women with endocrine responsive breast cancer who desire pregnancy.